HEALTHQUARTZ
Some U.S. employers are dropping weight loss drug coverage as use surges
Some U.S. employers are discontinuing coverage for weight loss drugs as usage increases, with 10% of large employers planning to eliminate the benefit next year due to rising costs.
Related Signal
Adjacent reporting
- US states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises
- Restrictions on obesity drug coverage force patients to pivot
- Should insurance cover weight loss drugs?
- This CEO wants to cover weight loss drugs for employees. They're just too expensive.
- CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash
- STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more